Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery

Journal of Vascular Surgery

Volumn 37, Issue 3, 2003, Pages 636-643

  Zagon, Ian S ^a,b   Essis Jr , Frank M ^a   Verderame, Michael F ^a   Healy, Dean A ^a   Atnip, Robert G ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METENKEPHALIN; NALTREXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; OPIOID GROWTH FACTOR; OPIOID GROWTH FACTOR RECEPTOR; SODIUM CHLORIDE; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTORADIOGRAPHY; BALLOON CATHETER; BLOOD VESSEL INJURY; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENDOTHELIUM CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

EID: 0037347539     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2003.165     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-9.
2. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340:115-26.
3. Kraiss LW, Clowes AW. Response of the arterial wall to injury and intimal hyperplasia. In: Sidawy AN, Sumpio BE, DePalma RG, editors. The basic science of vascular disease. Armonk, NY: Futura Publishing; 1997. p 289-317.
4. Ip JH, Fuster V, Badimon L, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle proliferation. J Am Coll Cardiol 1990;15:1667-87.
5. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty: Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 1995;76:996-1002.
6. Healy D, Zierler R, Nicholls S, Clowes A, Primozich J, Bergelin K, et al. Long-term follow up and clinical outcome of carotid restenosis. J Vasc Surg 1989;10:662-9.
7. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointima smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
8. Smith JD, Bryant SR, Couper LL, Vary PH, Gotwals PJ, Koteliansky VE, et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Circ Res 1999;84:1212-22.
9. Niemann-Jonsson A, Ares MPS, Yan S-Q, Bu D-X, Fredrikson GN, Branen L, et al. Increased rate of apoptosis in intimal arterial smooth muscle cells through endogenous activation of TNF receptors. Arterioscler Thromb Vasc Biol 2001;21:1909-20.
10. DeYoung MB, Clifford T, Dichek DA. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries. Circulation 2001;104:1972-77.
11. Zagon IS, McLaughlin PJ. Opioid growth factor receptor in the developing nervous system. In: Zagon IS, McLaughlin PJ, editors. Receptors in the developing nervous system. Vol 1: Growth factors and hormones, London: Chapman and Hall; 1993. p 39-62.
12. Zagon IS, Verderame MF, McLaughlin PJ. The biology of the opioid growth factor receptor (OGFr). Brain Res Rev 2002;38:351-76.
13. 5]-enkephalin, preproenkephalin gene expression, and the ζ opioid receptor in the developing and adult aorta of rat. Dev Dynamics 1998;211:327-37.
14. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor-dependent DNA synthesis in the neonatal rat aorta. Am J Physiol 1996;270:R22-32.
15. Blebea J, Mazo JE, Kihara TR, Vu JH, McLaughlin PJ, Atnip RC, et al. Opioid growth factor modulates angiogenesis. J Vasc Surg 2000;32:364-73.
16. Blebea J, Vu JH, Assadnia S, McLaughlin PJ, Atnip RC, Zagon IS. Differential effects of vascular growth factors on arterial and venous angiogenesis. J Vasc Surg 2002;35:532-8.
17. Akil H, Watson SJ, Young E, Lewis ME, Katchaturian H, Walter JM. Endogenous opioids: Biology and function. Annu Rev Neurosci 1984;7:233-55.
18. Armstead WM. Role of opioids in hypoxic pial artery dilation is stimulus duration dependent. Am J Physiol 1998;275:H861-7.
19. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I: Smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-33.
20. Clowes AW, Reidy MA, Clowes MM. Mechanism of stenosis after arterial injury. Lab Invest 1983;49:208-15.
21. 5]-enkephalin, in rats. Brain Res Bull 2001;55:341-6.
22. Zagon IS, McLaughlin PJ. Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: A role for endogenous opioid systems in cancer. Life Sci 1984;35:409-16.
23. Capron L, Janet J, Heudes D, Joseph-Monrose D, Bruneval P. Repeated balloon injury of rat aorta: A model of neointima with attenuated inhibition by heparin. Arterioscler Thromb Vasc Biol 1997;17:1649-56.
24. Buchwald AB, Unterberg C, Nebendahl K, Grone H-J, Wiegand V. Low-molecular-weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs. Circulation 1992;86:531-7.
25. Olivetti G, Anversa P, Melissari M, Loud AV. Morphometric study of early postnatal development of the thoracic aorta in the rat. Circ Res 1980;47:417-24.
26. Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III: Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986;54:295-303.
27. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985;56:139-45.
28. Fingerle J, Au YP, Clowes AW, Reidy MA. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990;10:1082-7.
29. Zagon IS, Sassani JW, McLaughlin PJ. Opioid growth factor modulates corneal epithelial growth in tissue culture. Am J Physiol 1995;268:R942-50.
30. Zagon IS, Wylie, JD, McLaughlin PJ. Opioid growth factor (OGF) does not mediate growth through apoptotic and/or necrotic pathways [abstract]. Society Neuroscience 2002, 428.4.
31. Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ, McLaughlin. Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol 2000;17:1053-61.
32. Newby AC, George SJ. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc Res 1993;27:1173-83.
33. Chang MW, Barr E, Seltzer J, Jiang Y-Q, Nabel GJ, Nabel EG, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995;267:518-22.
34. Welt FGP, Woods TC, Edelman ER. Oral heparin prevents neointimal hyperplasia after arterial injury: Inhibitory potential depends on type of vascular injury. Circulation 2001;104:3121-4.